ISSN: 2167-065X

Klinische Pharmakologie und Biopharmazeutik

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Nanotechnology in Pharmaceutical Delivery System

Zhen Huang

Nanotechnology has revolutionized the field of drug delivery in the pharmaceutical industry. With the development of Nano scale particles and structures, drugs can now be targeted and delivered to specific sites within the body with greater precision and efficacy. One of the key advantages of nanotechnology in drug delivery is the ability to increase drug solubility, bioavailability, and stability. This is achieved by encapsulating drugs in Nano scale particles, which can protect them from degradation and enhance their absorption in the body. Additionally, nanoscale drug delivery systems can be designed to release drugs in a controlled manner, ensuring sustained therapeutic effects and minimizing potential side effects. Furthermore, nanotechnology-based delivery systems can be engineered to selectively target diseased cells or tissues, thereby reducing off-target effects and improving treatment outcomes. Overall, the use of nanotechnology in pharmaceutical delivery systems holds great promise for improving the effectiveness and safety of drug therapies. As such, it is an area of active research and development in the pharmaceutical industry.